Pharmaceutical companies are advancing the science of treatment beyond traditional medications. New technologies—from radiopharmaceuticals to immunotherapy to mobile apps—are redefining the industry. For IP professionals, these revolutionary advances demand new strategies for clearing and protecting pharma trademarks that go beyond the traditional Class 5 model. In this webinar, two legal professionals explore this fascinating development from both the law firm and in-house counsel perspective, offering best practices for maximizing trademark protection while minimizing the risk of rejection.
We will be covering the following topics: